Page last updated: 2024-08-21

quinazolines and Anemia, Congenital Hypoplastic, Of Blackfan And Diamond

quinazolines has been researched along with Anemia, Congenital Hypoplastic, Of Blackfan And Diamond in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agarwal, S; Alter, BP; Barragan, J; Beggs, AH; Daley, GQ; DeVine, A; Doulatov, S; Ebert, BL; Gazda, HT; Gupta, M; Humphries, JM; Kinney, MA; Lee, HY; Lodish, HF; Macari, ER; McGrath, K; Narla, A; Schlaeger, TM; Sieff, CA; Taylor, AM; Vo, LT; Wahlster, L; Zon, LI1

Other Studies

1 other study(ies) available for quinazolines and Anemia, Congenital Hypoplastic, Of Blackfan And Diamond

ArticleYear
Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors.
    Science translational medicine, 2017, 02-08, Volume: 9, Issue:376

    Topics: Allyl Compounds; Anemia, Diamond-Blackfan; Antigens, CD34; Autophagy; Autophagy-Related Protein 5; Cell Differentiation; Cellular Reprogramming; Drug Discovery; Erythroid Cells; Erythropoiesis; Genetic Complementation Test; Globins; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Induced Pluripotent Stem Cells; Quinazolines

2017